Global Digital Therapeutics For Fibromyalgia Market Forecasted to Reach $2.53 Billion in Value by 2029

 Grab 20% Off With Code ONLINE20 On Global market Reports — Evaluate Global Trends, Market Risks, and Competitive Intelligence

 

 What Is the Estimated Market Size and CAGR of the Digital Therapeutics For Fibromyalgia Market for the Period 2025–2029?
 The digital therapeutics for fibromyalgia market size has grown exponentially in recent years. It will grow from $0.98 billion in 2024 to $1.19 billion in 2025 at a compound annual growth rate (CAGR) of 21.3%. The growth in the historic period can be attributed to growing clinical recognition of fibromyalgia and earlier diagnosis, a shift to home-based self-management during the coronavirus pandemic, insurer and employer preference for nonpharmacological pain management, opioid stewardship policies favoring behavioral pain therapies, and rising patient preference for non-drug low-risk pain interventions.
 
 The digital therapeutics for fibromyalgia market size is expected to see exponential growth in the next few years. It will grow to $2.54 billion in 2029 at a compound annual growth rate (CAGR) of 20.9%. The growth in the forecast period can be attributed to expansion of reimbursement for evidence-based digital interventions, rising integration into rheumatology and primary care pathways, rising prevalence and symptom burden in aging populations, greater focus on women’s health and chronic pain equity, and cost-containment pressure to reduce unnecessary imaging and visits. Major trends in the forecast period include prescription digital therapeutics delivering acceptance and commitment therapy programs, virtual reality-based pain distraction and rehabilitation modules, augmented reality-guided movement therapy and posture training, artificial intelligence-driven personalization of therapy content and pacing, and natural language processing-powered coaching and symptom triage.
 
 Get your free report sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=29026&type=smp
 
 Which Factors Are Contributing Most to the Expansion of the Digital Therapeutics For Fibromyalgia Market?
 The growing awareness of digital health solutions are expected to propel the growth of the digital therapeutics for fibromyalgia market going forward. Digital health solutions are software-enabled tools and services such as patient apps, patient portals, and virtual-care platforms that deliver information, monitoring, and therapy through digital channels. The increasing awareness of digital health solutions is due to government-backed promotion and widespread adoption of official health apps that normalize online access to care. Digital therapeutics for fibromyalgia leverage this awareness by meeting patients in those familiar channels, streamlining onboarding and adherence to app-based cognitive behavioral therapy, pacing, and sleep programs while enabling clinician oversight. For instance, in December 2023, according to the National Health Service, a UK-based government department, digital health app users reached 33.6 million, up from 16.8 million in 2022, with monthly logins rising 54% from 16.8 million to 25.8 million. Therefore, the growing awareness of digital health solutions is driving the digital therapeutics for fibromyalgia market. 
 
 What Are the Emerging Segments Driving Growth in the Digital Therapeutics For Fibromyalgia Market?
 The digital therapeutics for fibromyalgiamarket covered in this report is segmented — 
 
 1) By Product Type: Software Applications, Devices, Platforms
 2) By Therapy Area: Cognitive Behavioral Therapy, Mindfulness-Based Interventions, Pain Management, Other Therapy Types
 3) By Distribution Channel: Online, Offline
 4) By Application: Chronic Pain Management, Sleep Disorders, Fatigue Management, Other Applications
 5) By End-User: Hospitals, Clinics, Homecare, Other End-Users
 
 Subsegments:
 1) By Software Applications: Mobile Applications, Web-Based Applications, Cloud-Based Applications, Virtual Reality Applications
 2) By Devices: Wearable Devices, Handheld Devices, Smart Monitoring Devices, Connected Therapeutics Devices
 3) By Platforms: Telehealth Platforms, Remote Monitoring Platforms, Patient Engagement Platforms, Data Analytics Platforms
 
 Which Future-Ready Trends Are Expected to Influence the Digital Therapeutics For Fibromyalgia Market?
 Major companies operating in the digital therapeutics for fibromyalgia market are focusing on technological advancements such as computerized behavioral therapy devices to deliver evidence-based interventions that improve pain management, reduce fatigue, enhance sleep quality, and support mental health, all through scalable, patient-centric digital platforms. A computerized behavioral therapy device refers to a software-based digital platform or application that delivers structured, evidence-based cognitive or behavioral therapy interventions to patients remotely, often using interactive modules, exercises, and real-time feedback to manage symptoms of conditions such as fibromyalgia. For instance, in May 2023, Swing Therapeutics, Inc., a US-based biopharmaceutical company, launched Stanza following U.S. FDA De Novo marketing authorization (DEN220083). It delivers a 12-week, self-guided acceptance and commitment therapy (ACT) program for fibromyalgia, with a randomized controlled trial in the lancet reporting significant clinical improvements. This is delivered via smartphone (iOS or Android), and meets patients in-app for convenient, at-home therapy.
 
 Which Companies Hold a Prominent Position in the Digital Therapeutics For Fibromyalgia Market?
 Major companies operating in the digital therapeutics for fibromyalgia market are Grünenthal GmbH, Hinge Health Inc., DarioHealth Corp., Kaia Health, CogniFit Inc., Big Health Ltd., Remedee Labs, HelloBetter GmbH, AppliedVR Inc., PainDrainer, Swing Therapeutics Inc., Fern Health Inc., JOGO Health Inc., LIN Health Inc., MoreGoodDays, Happify Health Inc., Click Therapeutics Inc., Wellthy Therapeutics Pvt. Ltd., FlexifyMe, SleepioRx.
 
 Get the detailed digital therapeutics for fibromyalgia market report today
 https://www.thebusinessresearchcompany.com/report/digital-therapeutics-for-fibromyalgia-global-market-report
 
 What Are the Fastest-Growing Regions in the Digital Therapeutics For Fibromyalgia Market?
 North America was the largest region in the digital therapeutics for fibromyalgia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company